Table 3. Results of the RespiCoV analyses for 150 samples from patients with suspected SARS-CoV-2 infection (negative = 66, positive = 84).
Sequences of 32 pathogens other than SARS-CoV-2 could be identified, with 23 pathogens in 17 of the 66 negative samples. Co-infections were identified in 8 of the SARS-CoV-2-positive samples.
| Negative | Cq 18–28 | Cq 29–33 | Cq 34–38 | |
|---|---|---|---|---|
| n = 66 | n = 35 | n = 24 | n = 25 | |
| SARS-CoV-2 pos. | 1 | 35 | 19 | 3 |
| SARS-CoV-2 neg. | 65 | 0 | 5 | 22 |
| Streptococcus pneumoniae | 2 | 2 | 1 | 0 |
| Epstein-Barr virus | 6 | 1 | 1 | 1 |
| Human cytomegalovirus | 4 | 0 | 0 | 0 |
| Herpes simplex virus 1 | 2 | 1 | 1 | 0 |
| Human adenovirus B1 | 3 | 0 | 0 | 0 |
| Rhinovirus A | 3 | 0 | 0 | 0 |
| Rhinovirus B | 2 | 0 | 0 | 0 |